Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)

被引：0
|
作者：
Takaiwa, Takuya
Tachibana, Hiromasa
Arita, Machiko
Ishida, Tadashi
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Idiopathic pulmonary fibrosis; Lung function testing; Chronic disease;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P785
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)
    Takaiwa, Takuya
    Tachibana, Hiromasa
    Arita, Machiko
    Ishida, Tadashi
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [2] The Efficacy and Safety Long-term Pirfenidone Therapy in Patients with Idiopathic Pulmonary Fibrosis
    Ogawa, Kazumasa
    Miyamoto, Atsushi
    Hanada, Shigeo
    Takahashi, Yui
    Murase, Kyoko
    Mochizuki, Sayaka
    Uruga, Hironori
    Takaya, Hisashi
    Morokawa, Nasa
    Kishi, Kazuma
    [J]. INTERNAL MEDICINE, 2018, 57 (19) : 2813 - 2818
  • [3] The long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)
    Valeyre, Dominique
    Albera, Carlo
    Bradford, Williamson
    Costabel, Ulrich
    King, Talmadge
    Noble, Paul
    Sahn, Steven
    du Bois, Roland
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [4] Long-Term Efficacy Of Pirfenidone For Idiopathic Pulmonary Fibrosis
    Bando, M.
    Yamauchi, H.
    Ogura, T.
    Taniguchi, H.
    Watanabe, K.
    Azuma, A.
    Homma, S.
    Sugiyama, Y.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [5] Patterns of discontinuation in the long-term RECAP study of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)
    Costabel, Ulrich
    Albera, Carlo
    Lancaster, Lisa H.
    de Andrade, Joao A.
    Trzaskoma, Benjamin
    Limb, Susan
    Noble, Paul W.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [6] EFFICACY OF PIRFENIDONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Inagaki, Ai
    Tsutsumi, Takeo
    Kuriyama, Sachiko
    Nagaoka, Tetsutaro
    Sekiya, Mitsuaki
    Morio, Yoshiteru
    Takahashi, Kazuhisa
    [J]. RESPIROLOGY, 2013, 18 : 135 - 135
  • [7] Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF)
    Balestro, Elisabetta
    Turato, Graziella
    Biondini, Davide
    Pavanello, Sofia
    Fraccaro, Alessia
    Rigobello, Chiara
    Bazzan, Erica
    Campisi, Manuela
    Baraldo, Simonetta
    Cosio, Manuel
    Saetta, Marina
    Spagnolo, Paolo
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [8] Mechanisms of treatment response to pirfenidone of idiopathic pulmonary fibrosis (IPF) patients
    Ronan, Nicola
    Khan, Kashif A.
    Subramaniam, Abirami
    McCarthy, Yvonne
    Burke, Louise
    Chelliah, A.
    Plant, Barry J.
    Henry, Michael T.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [9] ANTACID THERAPY AND DISEASE PROGRESSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) UNDER PIRFENIDONE TREATMENT
    Kreuter, M.
    Spagnolo, P.
    Wuyts, W.
    Renzoni, E.
    Koschel, D.
    Bonella, F.
    Maher, T. M.
    Kolb, M.
    Weycker, D.
    Kirchgassler, K.
    Costabel, U.
    [J]. THORAX, 2016, 71 : A58 - A58
  • [10] Molecular Modulation of Treatment Response of Idiopathic Pulmonary Fibrosis (IPF) Patients Following Pirfenidone Therapy
    O'Callaghan, G.
    Khan, K. A.
    McCarthy, Y.
    Houston, A. M.
    Subramaniam, A.
    Elshafi, M.
    Bourke, L.
    Plant, B. J.
    Henry, M. T.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S523 - S524
12345